6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9 PF-07321332 Boceprevir Kūwaena Kiʻi Hōʻikeʻike

6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9 PF-07321332 Boceprevir Intermediate

ʻO ka wehewehe pōkole:

Inoa Kemika: 6,6-Dimethyl-3-azabicyclo[3.1.0]hexane

CAS: 943516-54-9

ʻAno: ʻO ka wai alohilohi kala ʻole

Maʻemaʻe: ≥98.0%

Kūwaena o PF-07321332 Paxlovid (CAS 2628280-40-8) a me Boceprevir (CAS 394730-60-0)

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Mea Kūʻai Kūʻai PF-07321332 Paxlovid E pili ana i waena me ke kūlana kiʻekiʻe.
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9

Na Waiwai Kemika:

Inoa Kimia	6,6-Dimethyl-3-azabicyclo[3.1.0]hexane
Helu CAS	943516-54-9
Helu CAT	RF-PI316
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C7H13N
Kaumaha Molecular	111.18
Lae paila	135 ℃
ʻO ka mānoanoa	0.911
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	ʻO ka wai alohilohi kala ʻole
Maemae	≥98.0%
Hoʻokahi haumia	≤0.50%
Huina paumaele	≤2.0%
Nā Metala Kaumaha	≤20ppm
Kūlana hoʻāʻo	Kūlana ʻoihana
Hoʻohana	Kūwaena o PF-07321332 Paxlovid (CAS 2628280-40-8) a me Boceprevir (CAS 394730-60-0)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

FAQ:

Noi:

ʻO 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane (CAS 943516-54-9) ka waena o PF-07321332 Paxlovid (CAS 2628280-40-8) a me Boceprevir (CAS 394730-60-0).ʻO ka Pfizer's Paxlovid PF-07321332 kahi lāʻau lapaʻau antiviral waha e kuhikuhi ana i ka SARS-CoV-2 betacoronavirus e pale i ka COVID-19.ʻO Paxlovid kahi mea pale protease i hōʻike i ka hana antiviral in vitro e kūʻē iā SARS-CoV-2 a me nā coronaviruses ʻē aʻe, e hōʻike ana i ka hiki ke hoʻohana i ka mālama ʻana i ka COVID-19, a me ka hoʻohana ʻana i nā hoʻoweliweli virus e hiki mai ana, wahi a Pfizer.ʻO ka Boceprevir (EBP 520) he mea hoʻopaneʻe protease HCV NS3 me ka Ki o 14 nM i loko o nā hoʻokolohua enzyme ʻelua a me kahi EC90 o 350 nM i ka hoʻopiʻi replicon cell-based.Kāohi ʻo Boceprevir i ka hana SARS-CoV-2 3CLpro.